Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSME-IMMUN TBE Antibody Persistence and Second Booster Study
NCT00894686Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2009
- Primary completion
- May 2017
- Modality
- Whole Inactivated Vaccines
- Countries
- 3
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Pfizer. Started Apr 2009; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00894686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894686.